Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
79.8M
-
Shares change
-
+24.3M
-
Total reported value, excl. options
-
$780M
-
Value change
-
+$235M
-
Put/Call ratio
-
0.08
-
Number of buys
-
77
-
Number of sells
-
-47
-
Price
-
$9.77
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2020
151 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q1 2020.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.8M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.27M shares), Avoro Capital Advisors LLC (7.15M shares), Versant Venture Management, LLC (7.07M shares), RTW INVESTMENTS, LP (6.63M shares), BlackRock Inc. (5.04M shares), Sonic Fund II, L.P. (4.11M shares), ORBIMED ADVISORS LLC (3.45M shares), STATE STREET CORP (3.34M shares), VANGUARD GROUP INC (3.18M shares), and UBS Group AG (2.47M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.